Cleared Traditional

K030238 - BINDAZYME ANTI-MITOCHONDRIA M2 IGGAM EIA KIT (FDA 510(k) Clearance)

Mar 2003
Decision
60d
Days
Class 2
Risk

K030238 is an FDA 510(k) clearance for the BINDAZYME ANTI-MITOCHONDRIA M2 IGGAM EIA KIT. This device is classified as a Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control (Class II - Special Controls, product code DBM).

Submitted by The Binding Site, Ltd. (Santa Monica, US). The FDA issued a Cleared decision on March 24, 2003, 60 days after receiving the submission on January 23, 2003.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5090.

Submission Details

510(k) Number K030238 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 23, 2003
Decision Date March 24, 2003
Days to Decision 60 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code DBM — Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5090